Phenome-Wide Association Study of Latent Autoimmune Diabetes from a Southern Mexican Population Implicates rs7305229 with Plasmatic Anti-Glutamic Acid Decarboxylase Autoantibody (GADA) Levels
- PMID: 39337639
- PMCID: PMC11432505
- DOI: 10.3390/ijms251810154
Phenome-Wide Association Study of Latent Autoimmune Diabetes from a Southern Mexican Population Implicates rs7305229 with Plasmatic Anti-Glutamic Acid Decarboxylase Autoantibody (GADA) Levels
Abstract
Latent autoimmune diabetes in adults (LADA) is characterized by the presence of glutamate decarboxylase autoantibodies (GADA). LADA has intermediate features between type 1 diabetes and type 2 diabetes. In addition, genetic risk factors for both types of diabetes are present in LADA. Nonetheless, evidence about the genetics of LADA in non-European populations is scarce. This study aims to perform a genome-wide association study with a phenome-wide association study of LADA in a southeastern Mexican population. We included 59 patients diagnosed with LADA from a previous study and 3121 individuals without diabetes from the MxGDAR/ENCODAT database. We utilized the GENESIS package in R to perform the genome-wide association study (GWAS) of LADA and PLINK for the phenome-wide association study (PheWAS) of LADA features. Nine polymorphisms reach the nominal association level (1 × 10-5) in the GWAS. The PheWAS showed that rs7305229 is genome-wide and associated with serum GADA levels in our sample (p = 1.84 × 10-8). rs7305229 is located downstream of the FAIM2 gene; previous reports associate FAIM2 variants with childhood obesity, body mass index, body adiposity measures, lymphocyte CD8+ activity, and anti-thyroid peroxidase antibodies. Our findings reveal that rs7305229 affects the GADA levels in patients with LADA from southeastern Mexico. More studies are needed to determine if this risk genotype exists in other populations with LADA.
Keywords: Mexico; fas apoptotic inhibitory molecule 2; genome-wide association study; latent autoimmune diabetes of adults.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


Similar articles
-
Persistence of glutamic acid decarboxylase antibody (GADA) is associated with clinical characteristics of latent autoimmune diabetes in adults: a prospective study with 3-year follow-up.Diabetes Metab Res Rev. 2016 Sep;32(6):615-22. doi: 10.1002/dmrr.2779. Epub 2016 Mar 3. Diabetes Metab Res Rev. 2016. PMID: 26787598
-
Significance of combined screening for GADA, ICA, and IAA in new-onset type 2 diabetes mellitus in adults for early diagnosis of latent autoimmune diabetes.Clin Invest Med. 2025 Mar;48(1):24-28. doi: 10.3138/cim-2024-0157. Clin Invest Med. 2025. PMID: 40131217
-
Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function.Diabetes Metab J. 2020 Apr;44(2):260-266. doi: 10.4093/dmj.2019.0007. Epub 2019 Nov 12. Diabetes Metab J. 2020. PMID: 31769235 Free PMC article.
-
Type 1 Diabetes-related Autoantibodies in Different Forms of Diabetes.Curr Diabetes Rev. 2019;15(3):199-204. doi: 10.2174/1573399814666180730105351. Curr Diabetes Rev. 2019. PMID: 30058495 Review.
-
Past, present and future of latent autoimmune diabetes in adults.Diabetes Metab Res Rev. 2020 Jan;36(1):e3205. doi: 10.1002/dmrr.3205. Epub 2019 Jul 31. Diabetes Metab Res Rev. 2020. PMID: 31318117 Review.
Cited by
-
Molecular Research on Diabetes.Int J Mol Sci. 2025 Feb 21;26(5):1873. doi: 10.3390/ijms26051873. Int J Mol Sci. 2025. PMID: 40076500 Free PMC article.
References
-
- World Health Organization . Classification of Diabetes Mellitus. World Health Organization; Geneva, Switzerland: 2019.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous